Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
Recursion official investor newsroom · Indexed industry source record · Source published: Thu Oct 15 2026 12:31:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 15 2026 13:07:58 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock October 15, 2026 at 8:30 AM EDT PDF Version Salt Lake City, UT , Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development decoding biology to radically improve lives, today announced
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.